UPDATE 2-U.S. FDA approves drug to treat Duchenne muscular dystrophy
February 09, 2017 at 18:40 PM EST
Feb 9 (Reuters) - The U.S. Food and Drug Administration on Thursday approved a drug made by Marathon Pharmaceuticals to treat Duchenne muscular dystrophy (DMD), a devastating muscle-wasting disease that mainly affects young boys.
